Full Court upholds validity of Pfizer’s Dynastat patent

Adrian Ryan 2022-09-30 4:58 pm By Cindy Cameronne | Sydney

Please login to bookmark

A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au